Publisher
Springer International Publishing
Reference12 articles.
1. Zhang DZ, Zhu XY, Lv B, Cui CS, Han XM, Sheng XT, et al. Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure. Circ Cardiovasc Interv. 2014;7(4):473–81.
2. Baumgartner H, De Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Eur Heart J. 2020;41(43):4153–4.
3. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(12):1494–563.
4. Wilson WM, Shah A, Osten MD, Benson LN, Abraha N, Breitner D, et al. Clinical outcomes after percutaneous patent ductus arteriosus closure in adults. Can J Cardiol. 2020;36(6):837–43.
5. Hong TE, Hellenbrand WE, Hijazi ZM, Amplatzer I. Transcatheter closure of patent ductus arteriosus in adults using the Amplatzer duct occluder: initial results and follow-up. Indian Heart J. 2002;54(4):384–9.